Basics Xeris Pharmaceuticals, Inc. IPO Date: June 22, 2018 Sector: Healthcare Market Cap: $1.27B Activated in VL: True Average Daily Range Avg Daily Range: $0.18 | 3.41% Avg Daily Range (30 D): $0.13 | 2.02% Avg Daily Range (90 D): $0.12 | 2.28% Institutional Daily Volume Avg Daily Volume: 1.44M Avg Daily Volume (30 D): 2.44M Avg Daily Volume (90 D): 2.01M Trade Size Avg Trade Size (Sh.): 225 Avg Trade Size (Sh.) (30 D): 140 Avg Trade Size (Sh.) (90 D): 143 Institutional Trades Total Inst.Trades: 373 Avg Inst. Trade: $1.7M Avg Inst. Trade (30 D): $2.67M Avg Inst. Trade (90 D): $1.85M Avg Inst. Trade Volume: .38M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.93M Avg Closing Trade (30 D): $2.19M Avg Closing Trade (90 D): $1.6M Avg Closing Volume: 412.86K     News Aug 7, 2025 @ 3:55 PM Xeris (XERS) Q2 Revenue Jumps 49% Source: Jesterai May 9, 2024 @ 12:10 PM Xeris Biopharma (XERS) Reports Q1 Loss, Lags Reven... Source: Zacks Equity Research Apr 17, 2024 @ 11:24 AM Strength Seen in MediWound (MDWD): Can Its 14.3% J... Source: Zacks Equity Research Mar 30, 2024 @ 5:28 AM Xeris Biopharma: Checking-In On One Of My 'Top Ide... Source: Biologics Mar 5, 2024 @ 2:42 PM Why Xeris (XERS) Might Surprise This Earnings Seas... Source: Zacks Equity Research Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.01 $-.06 $-.03 Diluted EPS $-.01 $-.06 $-.03 Revenue $ 71.54M $ 60.12M $ 60.1M Gross Profit $ $ $ Net Income / Loss $ -1.93M $ -9.22M $ -5.11M Operating Income / Loss $ 4.48M $ -3.09M $ 1.68M Cost of Revenue $ $ $ Net Cash Flow $ .85M $ -13.18M $ 12.39M PE Ratio